Half-year report · HY
6823.TEDINET S100X28N
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥39.7bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥39.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥38.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥32.6bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥31.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥30.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥380m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥968m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥520m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥749m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥398m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥117.77 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.27 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Environmental Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Environmental Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Environmental Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥87m |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥593m |
| Particle Countersreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Particle Countersreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Particle Countersreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Environmental Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Environmental Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Environmental Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥139m |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥401m |
| Particle Countersreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Particle Countersreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Particle Countersreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 490
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of stocks of subsidiaries and affiliates inv cf | Prior1InterimDuration | -150495000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | InterimDuration | － | JPY |
| Other net inv cf | Prior1InterimDuration | -7998000 | JPY |
| Other net inv cf | InterimDuration | 14666000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -968082000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -380430000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -392941000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -516729000 | JPY |
| Other net fin cf | Prior1InterimDuration | -5073000 | JPY |
| Other net fin cf | InterimDuration | -3472000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -398015000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -520202000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | 6584000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 19109000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 789576000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 1365440000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 4860213000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 5848615000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 5649790000 | JPY |
| Cash and cash equivalents | InterimInstant | 7214055000 | JPY |
| Finished goods | Prior1YearInstant | 2314683000 | JPY |
| Finished goods | InterimInstant | 2455293000 | JPY |
| Work in process | Prior1YearInstant | 1692584000 | JPY |
| Work in process | InterimInstant | 1764157000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 4027283000 | JPY |
| Raw materials and supplies | InterimInstant | 4023570000 | JPY |
| Salaries sga | Prior1InterimDuration | 1590044000 | JPY |
| Salaries sga | InterimDuration | 1558766000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 502350000 | JPY |
| Provision for bonuses sga | InterimDuration | 490040000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 79133000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 79297000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1InterimDuration | -1354000 | JPY |
| Provision of allowance for doubtful accounts sga | InterimDuration | 655000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01842-000ParticleCountersReportableSegmentMember | 4599480000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01842-000MedicalEquipmentReportableSegmentsMember | 5999884000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 2441221000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 13040586000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 13040586000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01842-000ParticleCountersReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01842-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01842-000ParticleCountersReportableSegmentMember | 4599480000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01842-000MedicalEquipmentReportableSegmentsMember | 5999884000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 2441221000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 13040586000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |